In breast cancer and colorectal cancer, TRPM2 activates NRF2 signaling to enhance resistance to oxidative stress [124, 125], while TRPA1 in glioblastoma alters mitochondrial dynamics and triggers apoptosis via increased fission, Ca2+ influx, and ROS production [126]. This evidence concerns the gene TRPA1 and breast cancer.